When MnK inhibitors were applied to in vitro and in vivo models of melanoma, lymphoma, colon cancer, and lung cancer, blocking the phosphorylation of eIF4E was found to inhibit cell proliferation and metastasis [203]. This evidence concerns the gene EIF4E and lung cancer.